The borough council, in a split 4-3 vote, decided not to renew the contract of Manager Kevin Swogger during its Monday ...

The Chamber’s Government Affairs Committee will host “Eggs & Issues: Pre-Legislative Session Breakfast with Our Local Delegation” Jan. 20 at 7:30 a.m. at the Ramada Plaza, 1809 Sugarland ...

Ellwood City residents will start 2026 with a three-mill tax increase, though borough council members hope to lower the millage rate in January. Council adopted the 2026 $16.7-million budget and tax ...

A rainy fall has turned a dry year normal, but not for long. The National Weather Service predicts the onset of La Niña cooling in the Pacific will produce another dry, warm winter in Arizona.

The Payson Water Department took a victory lap at the last council meeting as it highlighted its $4.3 million effort to replace water meters all over town. The department has so far replaced about ...

CHICAGO — The cyclists arrive at sunrise, rolling through Chicago's Latino neighborhoods and stopping at tamale carts, elote stands and candy stalls. They buy out every last item — every tamale, every ...

School of Chemical and Process Engineering, University of Leeds, Leeds LS2 9JT, U.K.

STURGIS — Nearly 400 staff members gathered Wednesday in the West Gym as Meade Superintendent Wayne Wormstadt welcomed them back for the 2025-2026 school year. Wormstadt reflected on the district’s ...

Remegen Co. Ltd. is out-licensing its VEGF/FGF dual-target fusion protein drug, RC28-E, to Santen Pharmaceutical (China) Co. Ltd. in a carve-out deal worth more than ¥1.3 billion (US$180 million).

RemeGen Co., Ltd., a leading Chinese biopharmaceutical company, announced that it has entered into an agreement with Santen Pharmaceutical (China) Co., Ltd. (Santen China), a wholly-owned subsidiary ...

Japanese ophthalmology major Santen Pharmaceutical (TYO: 4536) has licensed the Asia rights to Chinese biopharma RemeGen’s (HKEX: 9995) VEGF/FGF-targeted eye drug RC28-E, a PIII therapy for wet ...